The specificity of TET2/ASXL1 mutations (TA-CHIP) for adverse outcomes, contrasted with DNMT3A’s marginal significance, further refines the genetic architecture of ACS risk beyond conventional polygenic scores.
← all excerpts
The predictive value of atherogenic index of plasma and clonal hematopoiesis of indeterminate potential among patients with STEMI-from a prospective cohort study.
1
—
—